On December 8, the 16th Asia-Pacific Vitreoretinal Society Congress (APVRS 2023) kicked off in Hong Kong. On the first day of the conference, ZEISS Medical presented the "ZEISS Global Special Contribution Award for New Ophthalmic Technologies" to Professor Li Xiaoxin, General Director of Xiamen Eye Center affiliated to Xiamen University, the headquarters of Huaxia Eye Hospital Group, in recognition of her outstanding contributions to the field of ophthalmology in China and her key role in promoting the development of new ophthalmic technologies.
As an important milestone in the field of ophthalmology in the Asia-Pacific region and one of the most important ophthalmological societies in the world, APVRS 2023 has attracted well-known experts, researchers and industry leaders from the Asia-Pacific region and beyond.
More than 300 participants attended the ZEISS Fundus Disease Digital Navigation Satellite Conference, which covered advanced technologies such as Artevo intraoperative OCT, Cirrus OCT and FORUM42. The practice and value of WORKPLACE for fundus diseases in clinical applications comprehensively demonstrates ZEISS's leading position in optimizing the detection and management of fundus diseases.
In addition to academic exchanges, the symposium also set up a special link - ZEISS Medical presented the "ZEISS Ophthalmic New Technology Global Special Contribution Award" to Professor Li Xiaoxin, and Mr. Bob Gibson, General Manager of ZEISS Medical Diagnostic Equipment Products, presented the award to Professor Li Xiaoxin.
Mr. Bob Gibson recalled, "Professor Li Xiaoxin is not only committed to the promotion and application of advanced ophthalmic technology and equipment, but also provides rich clinical data and research support through high-quality surgery, which has contributed valuable experience to the application of new technologies to the majority of Chinese ophthalmologists, and has greatly promoted the digitalization of ophthalmology and the development of fundus diseases in China. ”
On December 2, China's first Artevo Oct 3D digital navigation microscope was installed in Xiamen Eye Center affiliated to Xiamen University, the headquarters of Huaxia Eye Hospital Group. Professor Li Xiaoxin gave a lecture on the application of the latest intraoperative navigation OCT technology in retinal surgery. She analysed the current challenges of macular cleavage for high myopia, compared the results and safety of two different procedures, glass incision and vitreous ILM staining and peeling, and highlighted the innovation of ZEISS technology in medical care. "The ZEISS 3D digital navigation microscope combines dual navigation technology to provide doctors with more comprehensive guidance," she says. ”
In the sixth edition of the "Annual Top 2% Global Top Scientist List" released by Stanford University in the United States this year, Professor Li Xiaoxin of Huaxia Ophthalmology was selected into the "Lifetime Scientific Influence Ranking" and was also shortlisted in the global "2023 Scientific Influence Ranking". This not only marks Professor Li Xiaoxin's long-term outstanding scientific research performance in the field of ophthalmology, but also fully recognizes her global influence in the field of ophthalmology.
In May 2016, Professor Li Xiaoxin joined Huaxia Ophthalmology as a senior medical talent introduced by the Xiamen Municipal Party Committee and Municipal Government, and served as the general director of Xiamen Eye Center affiliated to Xiamen University. Under his guidance and guidance, the overall medical quality and scientific research strength of Xiamen Eye Center have been rapidly improved, especially in the field of vitreous surgery and fundus diseases, the center has successfully introduced and carried out more than ten new technologies such as intraocular fluid detection, ruthenium nuclide radiotherapy, intraocular and extraocular enucleation of fundus tumors, intrathecal injection of retinal arterial occlusion, artificial cornea, etc., and the diagnosis and treatment level is comparable to that of the world.
In addition, Professor Li Xiaoxin has continuously promoted the implementation of the concept of "one photo of the fundus, early knowledge of chronic diseases", promoted the development of diabetic eye disease screening, and greatly improved the attention of Chinese people to eye healthRelying on the national consultation platform for difficult eye diseases to gather high-quality resources, it provides scientific, standardized and systematic diagnosis and treatment services for patients with difficult eye diseases across the countryXiamen Eye Center has built a 5G remote diagnosis and treatment smart medical platform to break the barriers of time and space, and realize real-time access to patients' image diagnosis information, remote consultation, AI screening of eye diseases and other diagnosis and treatment behaviors. Under the leadership of Professor Li Xiaoxin, the overall scientific research strength of Huaxia Ophthalmology has been rising year after year.
In the field of ophthalmic medical services, known as the "best track", the gathering of experts and the coordinated development of medical education and research have always been the "accelerator" for the vigorous development of Huaxia Ophthalmology. As a large-scale ophthalmic medical chain group that manages 67 ophthalmology hospitals and 53 optometry centers across the country, Huaxia Ophthalmology has been following the pace of the "Healthy China" strategy, recruiting talents, and striving to build a highland of ophthalmic talents and technology, protecting the eye health of the whole people with benevolence and benevolence, and providing high-quality, professional, reassuring and intimate ophthalmic diagnosis and treatment services for patients at home and abroad.
This time, ZEISS Medical awarded the "ZEISS Ophthalmology New Technology Global Special Contribution Award" to Professor Li Xiaoxin, which is not only an affirmation of Professor Li Xiaoxin's outstanding contributions in the field of ophthalmology, but also a high affirmation of the scientific research level and talent strength of Huaxia Ophthalmology, and once again confirms the international level of the overall development of Huaxia Ophthalmology in terms of clinical, academic and scientific research.